{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:07:47Z","timestamp":1789369667867,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05866-w","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:46:53Z","timestamp":1789368413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimization and characterization of lipid-based nanocarriers for intranasal delivery in amyotrophic lateral sclerosis"],"prefix":"10.1007","author":[{"given":"Dhvani","family":"P. Padhiyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shital","family":"Butani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravish J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"5866_CR1","doi-asserted-by":"publisher","first-page":"111919","DOI":"10.1016\/j.biopha.2021.111919","volume":"141","author":"M Agrawal","year":"2021","unstructured":"Agrawal M, Saraf S, Pradhan M, Patel RJ, Singhvi G, Alexander A et al (2021a) Design and optimization of curcumin loaded nano lipid carrier system using box-behnken design. Biomed Pharmacother 141:111919","journal-title":"Biomed Pharmacother"},{"key":"5866_CR2","doi-asserted-by":"crossref","unstructured":"Agrawal M, Saraf S, Pradhan M, Patel RJ, Singhvi G, Alexander A (2021b) Design and optimization of curcumin loaded nano lipid carrier system using box-behnken design. Biomed Pharmacother, vol 141","DOI":"10.1016\/j.biopha.2021.111919"},{"issue":"8","key":"5866_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1208\/s12249-024-02954-z","volume":"25","author":"K Akbar","year":"2024","unstructured":"Akbar K, Rehman MU, Shah FA, Younas S, Al-Otaibi JS, Khan H (2024) Paroxetine loaded nanostructured lipid carriers based in-situ gel for brain delivery via nasal route for enhanced anti-depressant effect: In vitro prospect and in vivo efficacy. AAPS PharmSciTech 25(8):248","journal-title":"AAPS PharmSciTech"},{"key":"5866_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.22270\/jddt.v13i2.5938","volume":"13","author":"S Bagde","year":"2023","unstructured":"Bagde S, Mamidi HK (2023) Nanostructured lipid carriers of eperisone hydrochloride using quality by design approach. Journal of Drug Delivery & Therapeutics 13:2","journal-title":"Journal of Drug Delivery & Therapeutics"},{"issue":"1","key":"5866_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s11671-026-04646-y","volume":"21","author":"UK Biswas","year":"2026","unstructured":"Biswas UK, Bose A, Naskar S, Jana M (2026) Development and preclinical evaluation of quiniodochlor-loaded nanostructured lipid carrier-chitosan gel for topical antifungal therapy. Discover Nano 21(1):187","journal-title":"Discover Nano"},{"key":"5866_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.34172\/apb.2020.021","volume":"10","author":"I Chauhan","year":"2020","unstructured":"Chauhan I, Yasir M, Verma M, Singh A (2020) Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Adv Pharm Bull 10:150\u2013165","journal-title":"Adv Pharm Bull"},{"key":"5866_CR7","doi-asserted-by":"publisher","unstructured":"Cho H, Shukla S (2021) Role of edaravone as a treatment option for patients with amyotrophic lateral sclerosis. Pharmaceuticals 14:1\u201314. [Online]. Available: https:\/\/doi.org\/10.3390\/ph14010029","DOI":"10.3390\/ph14010029"},{"key":"5866_CR8","doi-asserted-by":"publisher","unstructured":"Connolly O, Gall LL, McCluskey G, Donaghy C, Duddy W, Duguez S (2020) A systematic review of genotype\u2013phenotype correlation across cohorts having causal mutations of different genes in als. J Pers Med 10:1\u201327. [Online]. Available: https:\/\/doi.org\/10.3390\/jpm10030058","DOI":"10.3390\/jpm10030058"},{"key":"5866_CR9","doi-asserted-by":"publisher","unstructured":"Costa C, Moreira J, Lobo JS, Silva A (2021) Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies. Acta Pharm Sin B 11:925\u2013940. [Online]. Available: https:\/\/doi.org\/10.1016\/j.apsb.2021.02.012","DOI":"10.1016\/j.apsb.2021.02.012"},{"issue":"9","key":"5866_CR10","doi-asserted-by":"publisher","first-page":"108192","DOI":"10.1016\/j.cclet.2023.108192","volume":"34","author":"L Dong","year":"2023","unstructured":"Dong L, Ding J, Zhu L, Liu Y, Gao X, Zhou W (2023) Copper carbonate nanoparticles as an effective biomineralized carrier to load macromolecular drugs for multimodal therapy. Chin Chem Lett 34(9):108192","journal-title":"Chin Chem Lett"},{"key":"5866_CR11","doi-asserted-by":"publisher","unstructured":"Dorst J, Ludolph A, Huebers A (2017) Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis. Ther Adv Neurol Disord, vol\u00a011. [Online]. Available: https:\/\/doi.org\/10.1177\/1756285617734734","DOI":"10.1177\/1756285617734734"},{"key":"5866_CR12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jsps.2021.07.015","volume":"29","author":"M Elmowafy","year":"2021","unstructured":"Elmowafy M, Al-Sanea M (2021) Nanostructured lipid carriers (nlcs) as drug delivery platform: Advances in formulation and delivery strategies. Saudi Pharm J 29:999\u20131012","journal-title":"Saudi Pharm J"},{"key":"5866_CR13","doi-asserted-by":"publisher","first-page":"123212","DOI":"10.1016\/j.biomaterials.2025.123212","volume":"319","author":"X Guo","year":"2025","unstructured":"Guo X, Zheng Q, Gao W, Xiao Y, Shi L, Lin F, Xiong Y, Zhang Y, Xu Q, Wang L et al (2025) Synergistic microglial modulation by laminarin-based platinum nanozymes for potential intracerebral hemorrhage therapy. Biomaterials 319:123212","journal-title":"Biomaterials"},{"key":"5866_CR14","doi-asserted-by":"publisher","unstructured":"Hodgson J (2023) Drug pipeline 2q23 \u2014 controversy and complexity. Nat Biotechnol 41:1041\u20131043. [Online]. Available: https:\/\/doi.org\/10.1038\/s41587-023-01886-6","DOI":"10.1038\/s41587-023-01886-6"},{"key":"5866_CR15","doi-asserted-by":"crossref","unstructured":"Kesharwani P, Bisht A, Handa M, Shukla R, Kesari M, Paliwal S, Paliwal S, Sharma S (2023) Systematic optimization, characterization of mycophenolic acid loaded nanostructured lipid carrier embedded nanogel for improved permeation and in vivo antipsoriatic activity. J Drug Deliv Sci Technol, vol\u00a089","DOI":"10.1016\/j.jddst.2023.105088"},{"key":"5866_CR16","doi-asserted-by":"crossref","unstructured":"Kesharwani D, Das Paul S, Paliwal R, Satapathy T (2023) Development, qbd based optimization and in vitro characterization of diacerein loaded nanostructured lipid carriers for topical applications. J Radiat Res Appl Sci, vol\u00a016","DOI":"10.1016\/j.jrras.2023.100565"},{"key":"5866_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.34172\/apb.2023.056","volume":"13","author":"S Khan","year":"2023","unstructured":"Khan S, Sharma A, Jain V (2023) An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Adv Pharm Bull 13:446\u2013460","journal-title":"Adv Pharm Bull"},{"key":"5866_CR18","doi-asserted-by":"publisher","first-page":"108601","DOI":"10.1016\/j.foodres.2019.108601","volume":"126","author":"M Kharat","year":"2019","unstructured":"Kharat M, McClements DJ (2019) Fabrication and characterization of nanostructured lipid carriers (nlc) using a plant-based emulsifier: Quillaja saponin. Food Res Int 126:108601","journal-title":"Food Res Int"},{"key":"5866_CR19","doi-asserted-by":"publisher","unstructured":"Longinetti E, Fang F (2019) Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol 32:771\u2013776. [Online]. Available: https:\/\/doi.org\/10.1097\/WCO.0000000000000730","DOI":"10.1097\/WCO.0000000000000730"},{"key":"5866_CR20","doi-asserted-by":"publisher","unstructured":"Mata S, Bussotti M, Mastio MD, Barilaro A, Piersanti P, Lombardi M, Cincotta M, Torricelli S, Leccese D, Sperti M, Rodolico G, Nacmias B, Sorbi S (2023) Epidemiology of amyotrophic lateral sclerosis in the north east Tuscany in the 2018\u20132021 period. ENeurologicalSci, vol\u00a031. [Online]. Available: https:\/\/doi.org\/10.1016\/j.ensci.2023.100457","DOI":"10.1016\/j.ensci.2023.100457"},{"key":"5866_CR21","doi-asserted-by":"publisher","unstructured":"Mead R, Shan N, Reiser H, Marshall F, Shaw P (2023) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov 22:185\u2013212. [Online]. Available: https:\/\/doi.org\/10.1038\/s41573-022-00612-2","DOI":"10.1038\/s41573-022-00612-2"},{"key":"5866_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/0250-474X.57282","volume":"71","author":"S Mukherjee","year":"2009","unstructured":"Mukherjee S, Ray S, Thakur R (2009) Solid lipid nanoparticles: A modern formulation approach in drug delivery system. Indian J Pharm Sci 71:349\u2013358","journal-title":"Indian J Pharm Sci"},{"key":"5866_CR23","doi-asserted-by":"crossref","unstructured":"Muntean P, Socaciu C, Socaciu M (2020) Lipid nanostructured particles as emerging carriers for targeted delivery of bioactive molecules: Applications in food and biomedical sciences (an overview). Bull Univ Agric Sci Vet Med Cluj-Napoca Food Sci Technol 77:37","DOI":"10.15835\/buasvmcn-fst:2020.0009"},{"issue":"1","key":"5866_CR24","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3762\/bjnano.14.66","volume":"14","author":"G Muraca","year":"2023","unstructured":"Muraca G, Ruiz ME, Gambaro RC, Scioli-Montoto S, Sbaraglini ML, Padula G, Cisneros JS, Chain CY, \u00c1lvarez VA, Huck-Iriart C et al (2023) Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies. Beilstein J Nanotechnol 14(1):804\u2013818","journal-title":"Beilstein J Nanotechnol"},{"issue":"5","key":"5866_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.31024\/ajpp.2023.9.5.3","volume":"9","author":"N Nagar","year":"2023","unstructured":"Nagar N, Pawar RS (2023) Formulation preparation and evaluation of raloxifene nanoparticles. Asian Journal of Pharmacy and Pharmacology 9(5):159\u2013165","journal-title":"Asian Journal of Pharmacy and Pharmacology"},{"key":"5866_CR26","doi-asserted-by":"publisher","unstructured":"Nowicka N, Juranek J, Juranek J, Wojtkiewicz J (2019) Risk factors and emerging therapies in amyotrophic lateral sclerosis. Int J Mol Sci, vol\u00a020. [Online]. Available: https:\/\/doi.org\/10.3390\/ijms20112616","DOI":"10.3390\/ijms20112616"},{"key":"5866_CR27","doi-asserted-by":"publisher","unstructured":"Onesti E, Schettino I, Gori M, Frasca V, Ceccanti M, Cambieri C, Ruoppolo G, Inghilleri M (2017) Dysphagia in amyotrophic lateral sclerosis: Impact on patient behavior, diet adaptation, and riluzole management. Front Neurol, vol\u00a08. [Online]. Available: https:\/\/doi.org\/10.3389\/fneur.2017.00094","DOI":"10.3389\/fneur.2017.00094"},{"issue":"4","key":"5866_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/pharmaceutics13040531","volume":"13","author":"AC Ortiz","year":"2021","unstructured":"Ortiz AC, Ya\u00f1ez O, Salas-Huenuleo E, Morales JO (2021) Development of a nanostructured lipid carrier (nlc) by a low-energy method, comparison of release kinetics and molecular dynamics simulation. Pharmaceutics 13(4):531","journal-title":"Pharmaceutics"},{"key":"5866_CR29","doi-asserted-by":"crossref","unstructured":"Padhiyar D, Sami A, Bariya A, Shah H, Mehta T, Butani S (2026) Solid lipid nanoparticles in improving the therapeutic effectiveness of anticancer compounds. In: Exploring nanocarriers in breast cancer management, pp 51\u201370. Elsevier","DOI":"10.1016\/B978-0-443-43826-4.00013-0"},{"key":"5866_CR30","doi-asserted-by":"crossref","unstructured":"Pandey M, Jain N, Kanoujia J, Hussain Z, Gorain B (2022) Advances and challenges in intranasal delivery of antipsychotic agents targeting the central nervous system. Front Pharmacol, vol\u00a013","DOI":"10.3389\/fphar.2022.865590"},{"key":"5866_CR31","doi-asserted-by":"publisher","unstructured":"Parikh RH, Patel RJ (2017) Nanoemulsions for intranasal delivery of riluzole to improve brain bioavailability: Formulation development and pharmacokinetic studies. Curr Drug Deliv 13:1130\u20131143. [Online]. Available: https:\/\/doi.org\/10.2174\/1567201813666151202195729","DOI":"10.2174\/1567201813666151202195729"},{"key":"5866_CR32","doi-asserted-by":"publisher","unstructured":"Patel R, Patel A, Patel H (2021) Stabilized amorphous state of riluzole by immersion-rotavapor method with synthesized mesoporous SBA-15 carrier to augment in-vitro dissolution. J Drug Deliv Sci Technol, vol\u00a061. [Online]. Available: https:\/\/doi.org\/10.1016\/j.jddst.2020.102270","DOI":"10.1016\/j.jddst.2020.102270"},{"issue":"1","key":"5866_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12668-024-01624-5","volume":"15","author":"P Patel","year":"2025","unstructured":"Patel P, Vaidya R, Kansara Y, Shah P, Kapoor DU, Prajapati BG (2025) Multivariate optimization of carbamazepine-loaded nanostructured lipid carriers for brain targeting and epilepsy management. BioNanoScience 15(1):156","journal-title":"BioNanoScience"},{"key":"5866_CR34","doi-asserted-by":"crossref","unstructured":"Pires P, Rodrigues M, Alves G, Santos A (2022) Strategies to improve drug strength in nasal preparations for brain delivery of low aqueous solubility drugs. Pharmaceutics, vol\u00a014","DOI":"10.3390\/pharmaceutics14030588"},{"key":"5866_CR35","doi-asserted-by":"crossref","unstructured":"Poonia N, Kharb R, Lather V, Pandita D (2016) Nanostructured lipid carriers: Versatile oral delivery vehicle. Futur Sci OA, vol\u00a02","DOI":"10.4155\/fsoa-2016-0030"},{"key":"5866_CR36","doi-asserted-by":"publisher","first-page":"100447","DOI":"10.1016\/j.hybadv.2025.100447","volume":"10","author":"M Prajapat","year":"2025","unstructured":"Prajapat M, Gholap AD, Shinde S, Padhiyar D, Butani S, Shah S, Rajput A (2025) 3d printing technology in microneedles: An emerging era in transdermal drug delivery. Hybrid Advances 10:100447","journal-title":"Hybrid Advances"},{"key":"5866_CR37","doi-asserted-by":"publisher","unstructured":"Radunovic A, Annane D, Rafiq M, Brassington R, Mustfa N (2017) Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst Rev, vol 2017. [Online]. Available: https:\/\/doi.org\/10.1002\/14651858.CD004427.pub4","DOI":"10.1002\/14651858.CD004427.pub4"},{"issue":"4","key":"5866_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1208\/s12249-025-03083-x","volume":"26","author":"AR Ramireddy","year":"2025","unstructured":"Ramireddy AR, Behara DK (2025) Development and optimization of eberconazole nanostructured lipid carrier topical formulations based on the qbd approach. AAPS PharmSciTech 26(4):87","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"5866_CR39","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/pharmaceutics17040478","volume":"17","author":"A Rani","year":"2025","unstructured":"Rani A, Kaur R, Aldahish A, Vasudevan R, Balaji P, Dora CP, Chandrasekaran B, Singh TG, Sharma R (2025) Nanostructured lipid carriers (nlc)-based topical formulation of hesperidin for effective treatment of psoriasis. Pharmaceutics 17(4):478","journal-title":"Pharmaceutics"},{"key":"5866_CR40","doi-asserted-by":"crossref","unstructured":"Rao J, Kumar B (2012) 3d blade root shape optimization. In: Inst Mech Eng - 10th Int Conf Vib Rotating Mach, pp 173\u2013188","DOI":"10.1533\/9780857094537.4.173"},{"key":"5866_CR41","doi-asserted-by":"publisher","unstructured":"Saitoh Y, Takahashi Y (2020) Riluzole for the treatment of amyotrophic lateral sclerosis. Neurodegener Dis Manag 10:343\u2013355. [Online]. Available: https:\/\/doi.org\/10.2217\/nmt-2020-0033","DOI":"10.2217\/nmt-2020-0033"},{"key":"5866_CR42","doi-asserted-by":"crossref","unstructured":"Samimi S, Maghsoudnia N, Eftekhari R, Dorkoosh F (2018) Lipid-based nanoparticles for drug delivery systems. In: Charact Biol Nanomater Drug Deliv Nanosci Nanotechnol Drug Deliv, pp 47\u201376","DOI":"10.1016\/B978-0-12-814031-4.00003-9"},{"key":"5866_CR43","doi-asserted-by":"crossref","unstructured":"Shen P, Huang K, Zhang X, Yin G, Qin M, Ma H, Fan Z, Liao Y (2025) Genetically engineered msc-derived hybrid cellular vesicles for ros-scavenging and mitochondrial homeostasis in hepatic ischemia-reperfusion injury. Materials Today Bio, p 102215","DOI":"10.1016\/j.mtbio.2025.102215"},{"key":"5866_CR44","first-page":"466","volume":"10","author":"S Sherafudeen","year":"2015","unstructured":"Sherafudeen S, Vasantha P (2015) Development and evaluation of in situ nasal gel formulations of loratadine. Res Pharm Sci 10:466\u2013476","journal-title":"Res Pharm Sci"},{"issue":"2","key":"5866_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1208\/s12249-024-02736-7","volume":"25","author":"D Sonawane","year":"2024","unstructured":"Sonawane D, Pokharkar V (2024) Quercetin-loaded nanostructured lipid carrier in situ gel for brain targeting through intranasal route: formulation, in vivo pharmacokinetic and pharmacodynamic studies. AAPS PharmSciTech 25(2):30","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"5866_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1208\/s12249-025-03277-3","volume":"27","author":"IE Taha","year":"2025","unstructured":"Taha IE, ElSohly MA, Mostafa N, Almutairi M, Ashour EA (2025) Utilizing hot-melt extrusion and spray drying techniques for preparation of liquid and solid cannabidiol nano-structured lipid carriers formulations. AAPS PharmSciTech 27(1):26","journal-title":"AAPS PharmSciTech"},{"key":"5866_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.partic.2010.01.003","volume":"8","author":"R Tantra","year":"2010","unstructured":"Tantra R, Schulze P, Quincey P (2010) Effect of nanoparticle concentration on zeta-potential measurement results and reproducibility. Particuology 8:279\u2013285","journal-title":"Particuology"},{"key":"5866_CR48","doi-asserted-by":"publisher","unstructured":"Teixeira M, Lopes C, Gon\u00e7alves H, Catita J, Silva A, Rodrigues F, Amaral M, Costa P (2022) Formulation, characterization, and cytotoxicity evaluation of lactoferrin functionalized lipid nanoparticles for riluzole delivery to the brain. Pharmaceutics, vol\u00a014. [Online]. Available: https:\/\/doi.org\/10.3390\/pharmaceutics14010185","DOI":"10.3390\/pharmaceutics14010185"},{"issue":"8","key":"5866_CR49","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3390\/ph16081151","volume":"16","author":"A Unnisa","year":"2023","unstructured":"Unnisa A, Chettupalli AK, Alazragi RS, Alelwani W, Bannunah AM, Barnawi J, Amarachinta PR, Jandrajupalli SB, Elamine BA, Mohamed OA et al (2023) Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: Statistical optimization and pharmacological evaluations. Pharmaceuticals 16(8):1151","journal-title":"Pharmaceuticals"},{"issue":"5","key":"5866_CR50","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1208\/s12249-024-02831-9","volume":"25","author":"D Y\u0131lmaz Usta","year":"2024","unstructured":"Y\u0131lmaz Usta D, Teksin ZS, Tugcu-Demiroz F (2024) Evaluation of emulgel and nanostructured lipid carrier-based gel formulations for transdermal administration of ibuprofen: Characterization, mechanical properties, and ex-vivo skin permeation. AAPS PharmSciTech 25(5):124","journal-title":"AAPS PharmSciTech"},{"key":"5866_CR51","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejpb.2022.02.010","volume":"172","author":"R Varela-Fern\u00e1ndez","year":"2022","unstructured":"Varela-Fern\u00e1ndez R, Garc\u00eda-Otero X, D\u00edaz-Tom\u00e9 V, Regueiro U, L\u00f3pez-L\u00f3pez M, Gonz\u00e1lez-Barcia M, Lema MI, Otero-Espinar FJ (2022) Lactoferrin-loaded nanostructured lipid carriers (nlcs) as a new formulation for optimized ocular drug delivery. Eur J Pharm Biopharm 172:144\u2013156","journal-title":"Eur J Pharm Biopharm"},{"issue":"18","key":"5866_CR52","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.3390\/molecules28186668","volume":"28","author":"X Wang","year":"2023","unstructured":"Wang X, Liu J, Ma Y, Cui X, Chen C, Zhu G, Sun Y, Tong L (2023) Development of a nanostructured lipid carrier-based drug delivery strategy for apigenin: Experimental design based on ccd-rsm and evaluation against nsclc in vitro. Molecules 28(18):6668","journal-title":"Molecules"},{"key":"5866_CR53","doi-asserted-by":"crossref","unstructured":"Wang H, Tang C, Zhang H, Guo L, Zou C, Zhang S, Liu J, Huang Q, Liu Y, Zhou W et\u00a0al (2025a) A biocompatible tea polyphenol nanoplatform for efficient cytosolic delivery of protein therapeutics. Journal of Controlled Release, p 114347","DOI":"10.1016\/j.jconrel.2025.114347"},{"issue":"5","key":"5866_CR54","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1208\/s12249-025-03160-1","volume":"26","author":"L Wang","year":"2025","unstructured":"Wang L, Zhang X, Qu J, Zhang Z, Wu W, Li W (2025b) Development, characterization, and molecular dynamics simulation of andrographolide nanosuspensions utilizing hummer acoustic resonance technology. AAPS PharmSciTech 26(5):169","journal-title":"AAPS PharmSciTech"},{"key":"5866_CR55","doi-asserted-by":"crossref","unstructured":"Xu J, Tao J, Wang J (2020) Design and application in delivery system of intranasal antidepressants. Front Bioeng Biotechnol, vol\u00a08","DOI":"10.3389\/fbioe.2020.626882"},{"key":"5866_CR56","doi-asserted-by":"crossref","unstructured":"Zainab N, Azeez\u00a0Basha SA, Mannan A (2024) Formulation, optimization and characterization: Thermosensitive intranasal nanostructured lipid carrier (nlc) in-situ gel of novel agomelatine to overcome the limitations of oral delivery. J Drug Deliv Therapeut 14:12","DOI":"10.22270\/jddt.v14i12.6889"},{"key":"5866_CR57","doi-asserted-by":"publisher","unstructured":"Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano P, Pagani W, Lodin D, Orozco G, Chinea A (2015) A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int, vol\u00a06. [Online]. Available: https:\/\/doi.org\/10.4103\/2152-7806.169561","DOI":"10.4103\/2152-7806.169561"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05866-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05866-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05866-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:47:02Z","timestamp":1789368422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05866-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":57,"alternative-id":["5866"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05866-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"6 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have acknowledged that ethical and professional conduct principles have been adhered to.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have given their consent for participation in the article.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have given their consent for the article to be published.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}